Organophosphate Poisoning in a Greenhouse Pesticide Applicator
A 29-year-old farmworker mixes and applies organophosphate insecticide in greenhouses and has 3 years of experience. Two days ago he applied for 4 hours wearing a half-face respirator; the cartridge had been used for several weeks and no fit check was done. That evening he developed headache, nausea, salivation, blurred vision, and muscle twitching. On evaluation his pulse is 52, BP 110/70, pupils are pinpoint, coarse crackles are heard at both bases, and fasciculations of the eyelids and calves are present. RBC cholinesterase is 38% of his preseason baseline and plasma cholinesterase is 30%. He was treated with atropine and pralidoxime and observed for 24 hours. Today he feels well and wants to return to work tomorrow.
1. What is the diagnosis and what acute management issues remain?
Read the worked answer
This is organophosphate poisoning with a cholinergic crisis, showing both muscarinic effects (salivation, bradycardia, miosis, bronchorrhea, blurred vision) and nicotinic effects (fasciculations). The exposure history, the spent respirator cartridge without a fit check, and the cholinesterase depression - RBC 38% of baseline and plasma 30% - confirm it. Acute management is atropine titrated to drying of secretions rather than a fixed dose, early pralidoxime before enzyme aging, oxygen, suction, and monitoring for respiratory failure. Although he feels well, he needs observation for intermediate syndrome at 24–96 hours and follow-up for delayed polyneuropathy. RBC cholinesterase is the better marker of exposure and should be followed serially.
2. When can he return to pesticide handling, and what criteria apply?
Read the worked answer
He should not return tomorrow. A worker with cholinesterase depression should not handle organophosphates until enzyme activity has recovered, with a commonly used threshold of at least 80% of baseline and some programs requiring return to baseline. RBC cholinesterase recovers slowly over weeks to months, while plasma cholinesterase recovers faster but is not the criterion for clearance. He needs serial monitoring every few days initially, and until recovery he can do non-pesticide work. He should also be assessed for intermediate syndrome and followed for delayed neuropathy. Re-entry intervals for the specific product apply independently, and the employer should not allow handling until the medical clearance is documented.
3. What prevention measures and regulatory requirements should be addressed?
Read the worked answer
Prevention starts with engineering controls: closed mixing and loading systems and ventilation in greenhouses. PPE must include the correct respirator with the appropriate cartridge, fit testing, and cartridge changes per the manufacturer and at breakthrough. Hygiene facilities, separate work clothing, and training under the Worker Protection Standard are required. Medical monitoring for handlers includes a baseline RBC cholinesterase and periodic testing during the season, with records kept. The employer should maintain applicator records, observe re-entry intervals, and notify workers. Check the product label for specific PPE and re-entry requirements, since state rules may be stricter. The spent cartridge and missed fit check should be reviewed as a system failure, not only as individual error.